Request for Notification From Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives on Food Safety Public Advisory Committee and Request for Nominations for Nonvoting Industry Representatives on Food Safety Public Advisory Committee, 32123-32124 [E7-11141]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 111 / Monday, June 11, 2007 / Notices
People 2010: Volumes I and II can be
purchased by calling (202) 512–1800
(cost $70.00 for printed version; $20.00
for CD–ROM). Another reference is the
Healthy People 2010 Final Review—
2001.
For one free copy of the Healthy
People 2010, contact: The National
Center for Health Statistics, Division of
Data Services, 3311 Toledo Road,
Hyattsville, MD 20782, or by telephone
at (301) 458–4636. Ask for HHS
Publication No. (PHS) 99–1256. This
document may also be downloaded
from: https://www.healthypeople.gov.
3. Definitions
rmajette on DSK8KYBLC1PROD with MISCELLANEOUS
For purposes of this announcement,
the following definitions apply:
Minority Populations—American
Indian or Alaska Native; Asian; Black or
African American; Hispanic or Latino;
and Native Hawaiian or Other Pacific
Islander (42 U.S.C. 300u–6, section 1707
of the Public Health Service Act, as
amended.)
Multicultural Partnerships—
Multicultural, multi-racial, and multiethnic entities comprising organizations
and individuals that have come together
for a common purpose and that function
independently on behalf of the
partnership’s members to address health
disparities within communities of color.
State and Territorial Office of
Minority Health—An entity formally
established by Executive Order, statute,
or a state health officer to improve the
health of racial and ethnic populations.
Systems Change—An effort to ensure
that the resources and infrastructure
necessary are available and accessible to
address minority health and health
disparities as well as the public health
and health care needs of the American
population in general. Structural and
functional components of the system
must also be present—components such
as information, data, and evaluation
capabilities; trained, motivated, and
culturally/linguistically appropriate
staff; and facilities, equipment, and
technologies appropriate for the needs
of public health/health care
professionals and the people they serve.
Dated: June 5, 2007.
Garth N. Graham,
Deputy Assistant Secretary for Minority
Health.
[FR Doc. 07–2893 Filed 6–8–07; 8:45 am]
BILLING CODE 4150–29–P
VerDate Mar<15>2010
12:15 Mar 07, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
SUMMARY: Notice is hereby given that
the Office of Research Integrity (ORI)
and the Assistant Secretary for Health
have taken final action in the following
case:
Wei Jin, Colorado State University:
Based on an investigation conducted by
Colorado State University (CSU) and
additional analysis and information
obtained by the Office of Research
Integrity during its oversight review, the
U.S. Public Health Service (PHS) found
that Mr. Wei Jin, former doctoral
candidate, Department of Chemistry,
CSU, engaged in research misconduct in
research funded by National Cancer
Institutes (NCI), National Institutes of
Health (NIH), grant R01 CA85419.
Specifically, Mr. Jin falsified data/
results by claiming he had performed a
novel total synthesis of renieramycin G,
when in fact, he obtained renieramycin
G through a relatively simple reaction
sequence from renieramycin M, a
natural product that was a gift to the
laboratory and that had been isolated by
others from the Thai sponge. Mr. Jin
included the falsified data/results in:
• His research notebooks and other
records of his research;
• His dissertation, ‘‘Asymmetric total
synthesis of (¥)-Reineramycin G and
studies toward the total synthesis of
Ecteinascidin-743’’;
• A manuscript, Jin, W. & Williams,
R., ‘‘Asymmetric total synthesis of (¥)Renieramycin G,’’ accepted by the
Journal of the American Chemical
Society; and
• Supplemental information relative
to the manuscript to be published
online.
ORI has implemented the following
administrative actions for a period of
three (3) years, beginning on May 8,
2007:
(1) Mr. Jin is debarred from eligibility
for any contracting or subcontracting
with any agency of the United States
Government and from eligibility or
involvement in nonprocurement
programs of the United States
Government referred to as ‘‘covered
transactions’’ as defined in HHS’
implementation of OMB Guidelines to
Agencies on Government-wide
Debarment and Suspension at 2 CFR
Part 376, et seq.; and
(2) Mr. Jin is prohibited from serving
in any advisory capacity to PHS,
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
32123
including but not limited to service on
any PHS advisory committee, board,
and/or peer review committee, or as a
consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
John Dahlberg,
Acting Director, Office of Research Integrity.
[FR Doc. 07–2866 Filed 6–8–07; 8:45 am]
BILLING CODE 4150–31–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Request for Notification From Industry
Organizations Interested in
Participating in Selection Process for
Nonvoting Industry Representatives on
Food Safety Public Advisory
Committee and Request for
Nominations for Nonvoting Industry
Representatives on Food Safety Public
Advisory Committee
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is requesting that
any industry organizations interested in
participating in the selection of
nonvoting industry representatives to
serve on its Food Advisory Committee
for the Center for Food Safety and
Applied Nutrition (CFSAN) notify FDA
in writing. A nominee may either be
self-nominated or nominated by an
organization to serve as a nonvoting
industry representative. Nominations
will be accepted for current vacancies
effective with this notice.
DATES: Any industry organization
interested in participating in the
selection of an appropriate nonvoting
member to represent industry interests
must send a letter stating that interest to
the FDA by July 11, 2007, for vacancies
listed in this notice. Concurrently,
nomination materials for prospective
candidates should be sent to FDA by
July 11, 2007.
ADDRESSES: All letters of interest and
nominations should be submitted in
writing to Carolyn Jeletic (see FOR
FURTHER INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT:
Carolyn Jeletic, Center for Food Safety
and Applied Nutrition; Office of
Regulations, Policy, and Social Sciences
(HFS–24); Food and Drug
Administration, 5100 Paint Branch
E:\ERIC\11JNN1.SGM
11JNN1
32124
Federal Register / Vol. 72, No. 111 / Monday, June 11, 2007 / Notices
Pkwy., College Park, MD 20740; 301–
436–1719; carolyn.jeletic@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: The
agency intends to add nonvoting
industry representative to its advisory
committee identified below:
I. CFSAN Food Advisory Committee
The Committee shall provide advice
primarily to Commissioner of Food and
Drugs and other appropriate officials, on
emerging food safety, food science,
nutrition, and other food-related health
issues that the FDA considers of
primary importance for its food and
cosmetics programs. The Committee
may be charged with reviewing and
evaluating available data and making
recommendations on the following
matters, such as those relating to: (1)
Broad scientific and technical food or
cosmetic related issues, (2) the safety of
new foods and food ingredients, (3)
labeling of foods and cosmetics, (4)
nutrient needs and nutritional
adequacy, and (5) safe exposure limits
for food contaminants. The Committee
may also be asked to provide advice and
make recommendations on ways of
communicating to the public the
potential risks associated with these
issues and on approaches that might be
considered for addressing the issues.
rmajette on DSK8KYBLC1PROD with MISCELLANEOUS
II. Selection Procedure
Any industry organization interested
in participating in the selection of an
appropriate nonvoting member to
represent industry interests should send
a letter stating that interest to the FDA
contact (see FOR FURTHER INFORMATION
CONTACT) within 30 days of publication
of this document. Within the
subsequent 30 days, FDA will send a
letter to each organization that has
expressed an interest, attaching a
complete list of all such organizations;
and a list of all nominees along with
their current resumes. The letter will
also state that it is the responsibility of
the interested organizations to confer
with one another and to select a
candidate, within 60 days after the
receipt of the FDA letter, to serve as the
nonvoting member to represent industry
interests for a particular committee. The
interested organizations are not bound
by the list of nominees in selecting a
candidate. However, if no individual is
selected within 60 days, the
Commissioner of Food and Drugs will
select the nonvoting member to
represent industry interests.
III. Application Procedure
Individuals may self nominate and/or
an organization may nominate on one or
more individuals to serve as a nonvoting
industry representative. A current
curriculum vitae and the name of the
committee of interest should be sent to
the FDA contact person within the 30
days. FDA will forward all nominations
to the organizations expressing interest
in participating in the selection process
for the committee. (Persons who
nominate themselves as nonvoting
industry representatives will not
participate in the selection process).
FDA has a special interest in ensuring
that women, minority groups,
individuals with physical disabilities,
and small businesses are adequately
represented on its advisory committees,
and therefore, encourages, nominations
for appropriately qualified candidates
from these groups. Specifically, in this
document, nominations for nonvoting
representatives of industry interests are
encouraged from the food production
and manufacturing industry, the dietary
supplement manufacturing industry, the
agricultural biotechnology
manufacturing industry.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: June 4, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. E7–11141 Filed 6–8–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Jkt 223001
Health centers receiving grant funding
under Section 330 of the Public Health
Service (PHS) Act are a major
component of America’s health care
safety net, the Nation’s ‘‘system’’ of
providing primary health care to
underserved communities and
vulnerable populations. Health centers
care for people regardless of their ability
to pay and whether or not they have
health insurance. They provide primary
health care, as well as services such as
transportation and translation. Many
health centers also offer dental, mental
heath, and substance abuse care. Grants
to health centers are administered by
HRSA’s Bureau of Primary Health Care
(BPHC). In an effort to encourage the
creation of new health centers and sites
as well as improve and strengthen
existing sites, HRSA periodically issues
new grant opportunities.
HRSA uses the following application
forms to administer and manage the
Federal Qualified Health Center. These
application forms are used by new and
existing FQHC’s to apply for grant and
non-grant opportunities, re-new their
grant or non-grant opportunities or
change their scope of project.
Estimates of annualized reporting
burden are as follows:
Periodically, the Health Resources
and Services Administration (HRSA)
Number of
respondents
General Information Worksheet ...................................................
P12 Planning General Information Worksheet ............................
BPHC Funding Request Summary ..............................................
Proposed Staff Profile ..................................................................
Income Analysis Form .................................................................
Community Characteristics ..........................................................
12:15 Mar 07, 2011
Proposed Project: The Health Center
Program Application Forms: (OMB No.
0915–0285 Extension)
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Type of application form
VerDate Mar<15>2010
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301)–443–1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
PO 00000
Frm 00069
1,021
300
1,021
1,021
1,021
1,021
Fmt 4703
Sfmt 4703
Responses
per
respondent
Total
responses
1
1
1
1
1
1
E:\ERIC\11JNN1.SGM
1,021
300
1,021
1,021
1,021
1,021
11JNN1
Hours per
response
3.0
12.0
0.5
6.0
15.0
12.0
Total burden
hours
3,063
3,600
510.5
6,126
15,315
12,252
]]>Agencies
[Federal Register Volume 72, Number 111 (Monday, June 11, 2007)]
[Notices]
[Pages 32123-32124]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-11141]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Request for Notification From Industry Organizations Interested
in Participating in Selection Process for Nonvoting Industry
Representatives on Food Safety Public Advisory Committee and Request
for Nominations for Nonvoting Industry Representatives on Food Safety
Public Advisory Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting that any
industry organizations interested in participating in the selection of
nonvoting industry representatives to serve on its Food Advisory
Committee for the Center for Food Safety and Applied Nutrition (CFSAN)
notify FDA in writing. A nominee may either be self-nominated or
nominated by an organization to serve as a nonvoting industry
representative. Nominations will be accepted for current vacancies
effective with this notice.
DATES: Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests must send a letter stating that interest to the FDA by July
11, 2007, for vacancies listed in this notice. Concurrently, nomination
materials for prospective candidates should be sent to FDA by July 11,
2007.
ADDRESSES: All letters of interest and nominations should be submitted
in writing to Carolyn Jeletic (see FOR FURTHER INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT: Carolyn Jeletic, Center for Food
Safety and Applied Nutrition; Office of Regulations, Policy, and Social
Sciences (HFS-24); Food and Drug Administration, 5100 Paint Branch
[[Page 32124]]
Pkwy., College Park, MD 20740; 301-436-1719;
carolyn.jeletic@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: The agency intends to add nonvoting industry
representative to its advisory committee identified below:
I. CFSAN Food Advisory Committee
The Committee shall provide advice primarily to Commissioner of
Food and Drugs and other appropriate officials, on emerging food
safety, food science, nutrition, and other food-related health issues
that the FDA considers of primary importance for its food and cosmetics
programs. The Committee may be charged with reviewing and evaluating
available data and making recommendations on the following matters,
such as those relating to: (1) Broad scientific and technical food or
cosmetic related issues, (2) the safety of new foods and food
ingredients, (3) labeling of foods and cosmetics, (4) nutrient needs
and nutritional adequacy, and (5) safe exposure limits for food
contaminants. The Committee may also be asked to provide advice and
make recommendations on ways of communicating to the public the
potential risks associated with these issues and on approaches that
might be considered for addressing the issues.
II. Selection Procedure
Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests should send a letter stating that interest to the FDA contact
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of
this document. Within the subsequent 30 days, FDA will send a letter to
each organization that has expressed an interest, attaching a complete
list of all such organizations; and a list of all nominees along with
their current resumes. The letter will also state that it is the
responsibility of the interested organizations to confer with one
another and to select a candidate, within 60 days after the receipt of
the FDA letter, to serve as the nonvoting member to represent industry
interests for a particular committee. The interested organizations are
not bound by the list of nominees in selecting a candidate. However, if
no individual is selected within 60 days, the Commissioner of Food and
Drugs will select the nonvoting member to represent industry interests.
III. Application Procedure
Individuals may self nominate and/or an organization may nominate
on one or more individuals to serve as a nonvoting industry
representative. A current curriculum vitae and the name of the
committee of interest should be sent to the FDA contact person within
the 30 days. FDA will forward all nominations to the organizations
expressing interest in participating in the selection process for the
committee. (Persons who nominate themselves as nonvoting industry
representatives will not participate in the selection process).
FDA has a special interest in ensuring that women, minority groups,
individuals with physical disabilities, and small businesses are
adequately represented on its advisory committees, and therefore,
encourages, nominations for appropriately qualified candidates from
these groups. Specifically, in this document, nominations for nonvoting
representatives of industry interests are encouraged from the food
production and manufacturing industry, the dietary supplement
manufacturing industry, the agricultural biotechnology manufacturing
industry.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: June 4, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E7-11141 Filed 6-8-07; 8:45 am]
BILLING CODE 4160-01-S
